3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 16, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

December 1, 2025

Conditions
Cirrhosis, LiverPortal HypertensionAdvanced Chronic Liver Disease
Interventions
DEVICE

3D-MRE

All imaging studies were performed by using a 3.0-T MRI system (Signa HDx, GE Healthcare) with an eight-channel phasedarray body coil.

DEVICE

HVPG

HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures.

Trial Locations (1)

210000

RECRUITING

Shengjing Hospital, Shenyang

All Listed Sponsors
collaborator

Zhongda Hospital

OTHER

lead

Shengjing Hospital

OTHER